参考文献/References:
[1] 陈浩,冯飞,朱富强,等.老年骨折患者25-羟基维生素D和甲状旁腺素与骨质疏松程度的相关性[J].中华骨质疏松和骨矿盐疾病杂志,2013,6(1):20-27.
[2] 赵光,沈霖,杨艳萍.青娥丸对绝经后骨质疏松症患者骨密度、血清MMP-2水平及骨代谢指标的影响[J].中西医结合研究,2012,4(3):113-117.
[3] 徐晓娟,沈霖,杨艳萍,等.青娥丸对绝经后骨质疏松症患者骨密度和骨转换标志物的影响[J].中国中医骨伤科杂志,2013,21(6):8-10.
[4] 帅波,沈霖,杨艳萍,等.补肾活血方治疗早期缺血性股骨头坏死患者的临床研究[J].中国中医骨伤科杂志,2013,21(1):11-14.
[5] 张建梅,李瓦里.植物雌激素防治绝经后骨质疏松的研究进展[J].现代药物与临床,2012,27(1):65-69.
[6] Mohamad S,Shuid AN,Mohamed N.The effects of alpha-tocopherol supplementation on fracture healing in a postmenopausal osteoporotic rat model[J].Clinics,2012,67(9):1077-1085.
[7] Takada T,Iba K,Yoshizaki T,et al.Correlation between a bone resorption marker and structural geometry of the proximal femur in osteoporotic women treated with raloxifene[J].J Orthop Surg(Hong Kong),2012,20(2):209-213.
[8] 马芳远,高青房,朱秀华.原发性骨质疏松症临床药物治疗新进展[J].中国老年保健医学.2013,11(1):48-49.
[9] 范鸣.抗骨质疏松症药鲑鱼降钙素长期使用具有致癌风险[J].药学进展,2013,37(4):188-189.
[10] Poole KE,Compston JE.Osteoporosis and its management[J].BMJ,2006,333(7581):1251-1256.
[11] Lata PF,Elliott ME.Patient assessment in the diagnosis,prevention,and treatment of osteoporosis[J].Nutr Clin Pract,2007,22(3):261-275.
[12] 牛煜.青娥丸治疗绝经后骨质疏松症疗效观察[J].深圳中西医结合杂志,2012,22(2):101-102.
[13] 翁泽斌,颜翠萍,张志杰,等.不同炮制品入药的青娥丸含药血清对人成骨细胞增殖、分化及矿化的影响[J].中国实验方剂学杂志,2015,21(6):165-169.
[14] Takeuchi Y.Diabetes mellitus and osteoporosis.Therapeutic strategy for osteoporosis in patients with diabetes mellitus[J].Clinical Calcium,2012,22(9):1410-1415.
[15] Bohm ER,Tufescu TV,Marsh JP.The operative management ofosteoporotic fractures of the knee:to fix or replace[J].J Bone and Joint Surg Br,2012,94(9):1160-1169.